Clinical Trial Update: Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of everolimus (RAD001) in combination with letrozole for postmenopausal women with locally advanced or metastatic b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)
• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Postmenopausal Women, Locally Advanced Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-03-26